Amgen Inc

Stock Chart, Company Information, and Scan Results

$360.45(as of Jul 13, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Amgen Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$360.45
Ticker SymbolAMGN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees31,500
CountyUSA
Market Cap$196,124.6M
EBIDTA16,918.0M
10-Day Moving Average364.81
P/E Ratio25.14
20-Day Moving Average356.76
Forward P/E Ratio16.34
50-Day Moving Average343.51
Earnings per Share14.35
200-Day Moving Average334.33
Profit Margin21.11%
RSI55.44
Shares Outstanding539.7M
ATR8.42
52-Week High388.36
Volume1,592,573
52-Week Low264.02
Most Recent Support Level361.03
Book Value9,190.0M
Most Recent Resistance Level375.25
P/B Ratio21.34
Upper Keltner375.70
P/S Ratio5.27
Lower Keltner337.83
Debt-to-Equity Ratio375.70
Next Earnings Date08/03/2026
Cash Surplus-12,917.0M
Next Ex-Dividend DateUnknown

Amgen is a leader in medicinal breakthroughs as it pioneered ways to use living cells to develop biological medicines. The biotech develops and commercializes drugs to treat conditions like cancer, cardiovascular disease, and bone health. The company’s top-selling drugs, Aranesp and Kyprolis, are used to treat anemia and cancer respectively.

Amgen Inc In Our Stock Scanner

As of Jul 14, 2026
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.